Monopar Therapeutics
MNPR
MNPR
14 hedge funds and large institutions have $182K invested in Monopar Therapeutics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$55.8K | |
| 2 | +$15.3K | |
| 3 | +$7K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.96K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$50 |
Top Sellers
| 1 | -$7.84K | |
| 2 | -$7.18K | |
| 3 | -$1.98K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$393 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$128 |